Clinical Trials Browser

Has results × Head and Neck Neoplasms × Erlotinib Hydrochloride × Clear all

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00720304 2024-08-22

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

Phase 2 Completed

43 enrolled 16 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00573989 2019-01-03

Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer

Phase 1/2 Terminated

27 enrolled 18 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00304278 2017-07-27

Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)

Phase 2 Completed

21 enrolled 11 charts

Head & Neck

Head and Neck Neoplasms

NCT00970502 2017-04-10

Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer

Phase 1/2 Completed

15 enrolled 16 charts

Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

NCT00412217 2016-11-25

A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer

Phase 3 Terminated

94 enrolled 6 charts

Head & Neck

Head and Neck Neoplasms

NCT00570232 2015-05-21

UAB0718

Phase 2 Completed

31 enrolled 18 charts

Head & Neck

Head and Neck Neoplasms

NCT00392704 2013-02-22

Treatment of Head & Neck Cancer With Chemotherapy and Radiation

Phase 2 Completed

60 enrolled 6 charts

Head & Neck

Head and Neck Neoplasms

NCT00140556 2013-01-18

Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

Phase EARLY_PHASE1 Completed

28 enrolled 8 charts

Head & Neck

Head and Neck Neoplasms, Pharyngeal Neoplasms, Tonsillar Neoplasms

Clinical Trials

Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer

Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)

Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer

A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer

UAB0718

Treatment of Head & Neck Cancer With Chemotherapy and Radiation

Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer